Indoco Remedies Limited — Credit Ratings, 04-08-2025: Credit Rating- Revision

Indoco Remedies has seen its long-term credit ratings downgraded by ICRA, with a continued negative outlook. This action stems from a significant decline in the company's revenues, operating profit margins, and debt metrics in FY2025, a trend that persisted into Q1 FY2026. The weaker performance is primarily attributed to supply-side disruptions from ongoing manufacturing plant refurbishment and remediation at its Goa facility, which hit export sales and operating margins. Additionally, investments in the OTC toothpaste segment weighed on profitability. ICRA expects high debt levels to continue impacting debt metrics in FY2026. This downgrade could lead to higher borrowing costs and potentially dampen investor confidence, limiting strategic flexibility.